Related content

Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS

By      

Molecular Medicine Reports, Vol. 5, Iss. 6, 2012-01 ,pp. : 1531-1535

Spandidos Publications

Access to resources Recommend Favorite

Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS

By Yang Shuanying   Nan Yandong   Tian Yingxuan   Zhang Wei   Zhou Bin   Bu Lina   Huo Shufen   Chen Guoan   Yu Jiekai   Zheng Shu  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 380-386

Humana Press, Inc

Access to resources Recommend Favorite

Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker

By Chen Lei   Ho David   Lee Nikki   Sun Stella   Lam Brian   Wong Kwong-Fai   Yi Xin   Lau George   Ng Eddy   Poon Terence   Lai Paul   Cai Zongwei   Peng Jirun   Leng Xisheng   Poon Ronnie   Luk John  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2518-2525

Springer Publishing Company

Access to resources Recommend Favorite

Discovery of serum biomarkers in astrocytoma by SELDI–TOF MS and proteinchip technology

By Zhang Haishi   Wu Gang   Tu Hong   Huang Fengping  

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 315-323

Springer Publishing Company

Access to resources Recommend Favorite

Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 4, 2016-02 ,pp. : 424-431

Bentham Science Publishers

Access to resources Recommend Favorite